Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Abstract

Pharmaceutical industry funding has transformed much grassroots community activism on health into corporate-sponsored advocacy. This critical commentary outlines recent evidence about industry funding of patient advocacy groups, offers a commentary on the history of grassroots activism appearing in this issue of the journal, and calls for greater scrutiny of the impacts and ethics of such sponsorship.

Original languageEnglish
JournalJournal of Bioethical Inquiry
Early online date24 Mar 2020
DOIs
Publication statusE-pub ahead of print - 24 Mar 2020

    Fingerprint

Cite this